Malaria and HIV co-infection presents a significant public health challenge, particularly in Sub-Saharan Africa, where co-morbidity rates are highest. Conventional therapies, including antiretrovirals and antimalarial drugs, are expensive and often associated with side effects that lead to noncompliance. Traditional medicinal plants offer an affordable and culturally accepted alternative. This review explores various plants used historically in the treatment of both malaria and HIV, focusing on their phytochemical constituents, mechanisms of action, and clinical efficacy. Plants such as Catharanthus roseus, Adenia venenata, and Morinda lucida have demonstrated antimalarial and antiviral properties, often through bioactive compounds like alkaloids and flavonoids. Additionally, integrating these traditional medicines with modern healthcare systems faces regulatory challenges, but there is promising potential for synergies in treatment efficacy. Further research, clinical trials, and interdisciplinary collaboration are necessary to validate these medicinal plants and improve the management of malaria and HIV co-infection. Keywords: Traditional medicinal plants, Malaria, HIV co-infection, Phytochemicals, Antimalarial properties.
Read full abstract